Objective To evaluate association between biomarkers and outcomes in COVID-19
hospitalised patients. COVID-19 pandemic has been a challenge. Biomarkers have always …

The clinical course and outcome of COVID-19 are highly variable, ranging from
asymptomatic infections to severe disease and death. Understanding the risk factors of …

Background This study applies an umbrella review approach to summarise the global
evidence on the risk of severe COVID-19 outcomes in patients with pre-existing health …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a respiratory tract
virus that causes Coronavirus disease (COVID-19). The virus originated in Wuhan, China, in …

Background All countries are facing decisions about which population groups to prioritize for
access to COVID-19 vaccination after the first vaccine products have been licensed, at which …

The increasing COVID-19 cases in the USA have led to overburdening of healthcare in
regard to invasive mechanical ventilation (IMV) utilization as well as mortality. We aim to …

COVID-19 infections have spread quickly, resulting in massive healthcare burden to
societies worldwide. The most urgent interventions needed in the present climate include …

JCM | Free Full-Text | Lymphopenia as a Predictor for Adverse Clinical Outcomes in
Hospitalized Patients with COVID-19: A Single Center Retrospective Study of 4485 Cases …

BACKGROUND Coronavirus disease 2019 (COVID-19) has left a significant impact on the
world's health, economic and political systems; as of November 20, 2020, more than 57 …

Background COVID-19 is a worldwide pandemic and has placed significant demand for
acute and critical care services on hospitals in many countries. Objectives To determine the …